Use of breast cancer associated membrane proteins (BCMP) for treatment, prophylaxis and diagnosis of breast cancer

Details for Australian Patent Application No. 2005218046 (hide)

Owner Oxford Glycosciences (UK) Ltd.

Inventors Stamps, Alasdair Craig; Terrett, Jonathan Alexander; Boyd, Robert Simon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005218046

Parent 2001233929

Filing date 30 September 2005

Wipo publication date 27 October 2005

Acceptance publication date 3 July 2008

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

20 October 2005 Complete Application Filed

27 October 2005 Application Open to Public Inspection

  Published as AU-B-2005218046

3 July 2008 Application Accepted

  Published as AU-B-2005218046

30 October 2008 Standard Patent Sealed

22 October 2009 Assignment Registered

  Oxford Glycosciences (UK) Ltd. The patent has been assigned to UCB Pharma S.A.

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005218047-Derivatives of venlafaxine and methods of preparing and using the same

2005218045-Children's storybook with music player